Acadia Healthcare Company (ACHC) Stock Price
Acadia Healthcare Company Price
Revenue has compounded at 31.3% per year over the past 18 years to 3.31 B USD. Earnings per share have grown at 20.7% per year over the last 15 years. Acadia Healthcare Company's net margin stands at -33.3%, down from 8.2% several years earlier. Analysts set a median price target of 31.00 USD, implying 7.2% above the current price. Of 20 analysts, 13 rate the stock a buy — an overall Buy consensus.
Acadia Healthcare Company stock price
Acadia Healthcare Company business model & stock analysis
Frequently asked questions about Acadia Healthcare Company
The business model of Acadia Healthcare Company Inc is centered around providing behavioral healthcare services. As a leading provider in the industry, Acadia operates a network of psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic schools. Its comprehensive range of services caters to individuals with behavioral health disorders and substance use disorders, aiming to offer personalized care and support to patients across their treatment journey. By focusing on quality care, patient satisfaction, and strategic acquisitions, Acadia Healthcare Company Inc has established itself as a trusted provider in the behavioral healthcare industry.
Acadia Healthcare Company Inc is primarily active in the healthcare industry.
The main competitors of Acadia Healthcare Company Inc in the market are Universal Health Services, Inc., HCA Healthcare, Inc., and Tenet Healthcare Corporation.
Acadia Healthcare Company Inc is a renowned healthcare facility provider specializing in behavioral health services. Established in 2005, Acadia has grown into a leading global network of treatment centers, psychiatric hospitals, and outpatient clinics. The company operates across the United States, the United Kingdom, and Puerto Rico, offering comprehensive services for individuals facing mental health and addiction challenges. Emphasizing personalized care and evidence-based approaches, Acadia strives to improve patients' quality of life, providing specialized programs tailored to different age groups and needs. Continuously expanding its footprint and delivering exceptional behavioral healthcare, Acadia Healthcare Company Inc remains committed to assisting individuals on their journey to recovery.
Acadia Healthcare Company Inc, a renowned leader in behavioral healthcare, has accomplished several significant milestones over the years. The company has expanded its footprint, both domestically and internationally, establishing a vast network of facilities and treatment centers across various regions. Acadia Healthcare has consistently emphasized its commitment to quality patient care, investing in cutting-edge research, modern treatment methodologies, and innovative programs. The company's strong financial performance and successful acquisitions demonstrate its ability to navigate and thrive within the challenging healthcare industry. Furthermore, Acadia Healthcare has received accolades for its corporate governance practices and dedication to regulatory compliance, solidifying its position as a trusted provider in the behavioral healthcare sector.
Acadia Healthcare Company Inc is primarily present in the United States of America.
Acadia Healthcare Company Inc. represents values and a corporate philosophy centered around exceptional patient care and delivery of high-quality behavioral health services. With a commitment to clinical excellence, Acadia ensures patient safety, dignity, and respect while offering evidence-based treatment for individuals with mental health and addiction disorders. The company follows a patient-centered approach, focusing on personalized care plans tailored to meet each patient's unique needs. Acadia Healthcare Company Inc. also values integrity, transparency, and teamwork, fostering collaboration among their dedicated professionals and maintaining strong ethical standards.
Analysts currently set an average price target of 32.00 USD for the Acadia Healthcare Company stock (median: 31.00 USD), implying +10.6 % versus the latest price. The consensus is based on 20 analyst ratings.
20 analysts currently rate the Acadia Healthcare Company stock: 13 recommend buying, 6 holding and 1 selling. For 2026, analysts expect Acadia Healthcare Company to generate revenue of 3.43 B USD and earnings per share of 1.56 USD.
Converted at the current exchange rate, the Acadia Healthcare Company share trades at 25.81 EUR (28.93 USD).
The Acadia Healthcare Company share (ACHC) is listed on 3 stock exchanges, including: NASDAQ (ACHC), Frankfurt (7RA.F), München (7RA.MU).
Acadia Healthcare is an American company specializing in providing mental health services. It operates through its subsidiaries to serve patients in over 40 states in the US, the United Kingdom, and Puerto Rico. The company offers services for diagnosing and treating mental disorders, detoxification from substance abuse, and rehabilitation for addiction. It has inpatient and outpatient treatment options, focusing on creating safe and supportive environments for patients to concentrate on their recovery. Acadia Healthcare also provides administration services for mental health facilities, including recruitment, training, marketing, and compliance. It has made several acquisitions, such as the Priory Group and CRC Health Group, to expand its presence in the mental health and addiction treatment market. Overall, Acadia Healthcare aims to offer a wide range of services to support mental health and addiction treatment, utilizing both inpatient and outpatient programs, and ensuring efficient business processes for facilities offering mental health services.
The expected revenue of Acadia Healthcare Company is 3.43 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Acadia Healthcare Company is 140.81 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Acadia Healthcare Company is currently 18.58. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Acadia Healthcare Company stock.
The price-to-sales ratio (P/S) of Acadia Healthcare Company is currently 0.76. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Acadia Healthcare Company stock.
The Eulerpool Quality Score for Acadia Healthcare Company is 3/10.
The ISIN of Acadia Healthcare Company is US00404A1097. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Acadia Healthcare Company is A1JNMF. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Acadia Healthcare Company is ACHC. The ticker symbol is used to trade Acadia Healthcare Company shares on the stock exchange.
Acadia Healthcare Company stock
Acadia Healthcare Company Peer Group
Acadia Healthcare Company Ticker
Acadia Healthcare Company FIGI
All fundamentals and in-depth analysis of Acadia Healthcare Company
Our stock analysis for Acadia Healthcare Company stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acadia Healthcare Company. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.